Rhodiola Rosea for Coronary Microvascular Disease
Clinical trial NCT04218916 · UNKNOWN
Trial details
- NCT number
- NCT04218916
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-01-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.